Heterogeneity of AmpC cephalosporinases of Hafnia alvei clinical isolates expressing inducible or constitutive ceftazidime resistance phenotypes

Antimicrob Agents Chemother. 2000 Nov;44(11):3220-3. doi: 10.1128/AAC.44.11.3220-3223.2000.

Abstract

Ten unrelated Hafnia alvei clinical isolates were grouped according to either their low-level and inducible cephalosporinase production or their high-level and constitutive cephalosporinase production phenotype. Their AmpC sequences shared 85 to 100% amino acid identity. The immediate genetic environment of ampC genes was conserved in H. alvei isolates but was different from that found in other ampC-possessing enterobacterial species.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Ceftazidime / pharmacology*
  • Cephalosporinase / genetics*
  • Cephalosporinase / metabolism
  • Drug Resistance, Microbial
  • Electrophoresis, Gel, Pulsed-Field
  • Fenoterol
  • Genes, Bacterial*
  • Genetic Variation
  • Hafnia alvei / drug effects
  • Hafnia alvei / enzymology
  • Hafnia alvei / genetics*
  • Hafnia alvei / metabolism
  • Humans
  • Microbial Sensitivity Tests
  • Molecular Sequence Data
  • Plasmids / genetics
  • Sequence Homology, Amino Acid
  • beta-Lactamases / metabolism

Substances

  • Fenoterol
  • Ceftazidime
  • Cephalosporinase
  • beta-Lactamases

Associated data

  • GENBANK/AF180953
  • GENBANK/AF180954
  • GENBANK/AF180955
  • GENBANK/AF180956
  • GENBANK/AF180957
  • GENBANK/AF180958
  • GENBANK/AF180959
  • GENBANK/AF180960
  • GENBANK/AF180961